Matthew W Foehr's Net Worth
$25.9 Million
Who is Matthew W Foehr?
Matthew W Foehr has an estimated net worth of $25.9 Million. This is based on reported shares across multiple companies, which include OmniAb Operations, Inc., LIGAND PHARMACEUTICALS INC, Viking Therapeutics, Inc., RITTER PHARMACEUTICALS INC, OmniAb, Inc., CONNETICS CORP, and INTRACORP ENTERTAINMENT INC.
SEC CIK
Matthew W Foehr's CIK is 0001237556
Past Insider Trading and Trends
2022 was Matthew W Foehr's most active year for acquiring shares with 21 total transactions. Matthew W Foehr's most active month to acquire stocks was the month of October. 2005 was Matthew W Foehr's most active year for disposing of shares, totalling 15 transactions. Matthew W Foehr's most active month to dispose stocks was the month of January. 2023 saw Matthew W Foehr paying a total of $3,677,917.00 for 1,788,846 shares, this is the most they've acquired in one year. In 2006 Matthew W Foehr cashed out on 78,959 shares for a total of $1,215,408.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OmniAb Operations, Inc. No price found
CLO & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -186.17K |
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $75.31
President and COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.13% | -20.30K |
—
|
—
| 162.19K |
Nov 1
| |||
Form 4
| +5.27% | 9.14K |
—
|
—
| 182.49K |
Jun 10
| |||
Form 4
| +1.46% | 2.5K |
$82.76 | $206,909.50 | 173.35K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4/A
|
∞
| 16.67K |
—
|
—
| 16.67K |
Apr 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viking Therapeutics, Inc. (VKTX) Snapshot price: $24.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +67.92% | 45K |
$2.47 | $111,195.00 | 111.25K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +43.24% | 20K |
$5.69 | $113,800.00 | 66.25K |
Jun 10
| |||
Form 4
| +76.19% | 20K |
$1.50 | $30,000.00 | 46.25K |
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -33.12% | -13.00K |
$7.35 | -$95,550.00 | 26.25K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +49.52% | 13K |
$1.21 | $15,678.00 | 39.25K |
Nov 15
| |||
Form 4
| +320.00% | 20K |
$1.24 | $24,800.00 | 26.25K |
Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 6.25K |
$8.00 | $50,000.00 | 6.25K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RITTER PHARMACEUTICALS INC (QLGN) Snapshot price: $0.5025
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +496.25% | 115.38K |
—
|
—
| 138.63K |
Jan 21 - Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4/A
| +564.31% | 19.75K |
$2.04 | $40,292.04 | 23.25K |
Aug 17
| |||
Form 4
| +56.43% | 19.75K |
$2.04 | $40,292.04 | 54.75K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +105.88% | 18K |
$0.62 | $11,154.60 | 35K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 4
| +325.00% | 13K |
$1.64 | $21,320.00 | 17K |
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
∞
| 4K |
$5.00 | $20,000.00 | 4K |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OmniAb, Inc. (OABI) Snapshot price: $5.55
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +76.76% | 1.43M |
—
|
—
| 3.3M |
Nov 1
| |||
Form 4
| +0.57% | 17.98K |
$5.31 | -$98,112.87 | 3.17M |
Apr 7
| |||
Form 4
| +8.38% | 243.61K |
$3.72 | $907,023.21 | 3.15M |
Mar 27
| |||
Form 4
| +8.38% | 225K |
$5.19 | $1,167,750.00 | 2.91M |
Mar 22
| |||
Form 4
| +0.69% | 18.41K |
$5.54 | -$104,811.26 | 2.68M |
Feb 15 - Feb 16
| |||
Form 4
| +0.75% | 19.95K |
$6.25 | -$82,631.25 | 2.67M |
Jan 2
| |||
Form 4
| +8.18% | 200K |
$5.05 | $1,010,000.00 | 2.65M |
Dec 12
| |||
Form 4
| +0.72% | 17.37K |
$4.85 | -$44,542.40 | 2.45M |
Dec 7
| |||
Form 4
| +4.07% | 95K |
$4.27 | $405,517.00 | 2.43M |
Nov 10
| |||
Form 4
| +1.97% | 45K |
$5.48 | $246,600.00 | 2.33M |
Aug 14
| |||
Form 4
| +4.68% | 115K |
$4.52 | $519,800.00 | 2.57M |
Jun 9
| |||
Form 4
| +22.02% | 440K |
$3.40 | $1,496,000.00 | 2.44M |
May 12
| |||
Form 4
| +5.79% | 109.38K |
—
|
—
| 2M |
Apr 7
| |||
Form 4
| -0.90% | -17.09K |
$3.80 | -$64,926.80 | 1.89M |
Feb 15
| |||
Form 4
| +4.36% | 79.67K |
—
|
—
| 1.91M |
Jan 3
| |||
Form 4
| -0.63% | -11.62K |
$3.66 | -$42,543.84 | 1.83M |
Dec 28
| |||
Form 4
| +8.89% | 150K |
$3.77 | $564,765.00 | 1.84M |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
| -1.01% | -17.27K |
$3.35 | -$57,841.10 | 1.69M |
Dec 1
| |||
Form 4
| +21.35% | 300K |
$3.39 | $1,016,340.00 | 1.71M |
Nov 30
| |||
Form 4
| +7.66% | 100K |
$2.76 | $276,160.00 | 1.41M |
Nov 9
| |||
Form 4
|
∞
| 1.31M |
—
|
—
| 1.31M |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||